CogState Ltd
ASX:CGS

Watchlist Manager
CogState Ltd Logo
CogState Ltd
ASX:CGS
Watchlist
Price: 0.965 AUD -2.53% Market Closed
Market Cap: 166.7m AUD
Have any thoughts about
CogState Ltd?
Write Note

CogState Ltd
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CogState Ltd
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
CogState Ltd
ASX:CGS
Current Portion of Long-Term Debt
$108.4k
CAGR 3-Years
-44%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
4DMedical Ltd
ASX:4DX
Current Portion of Long-Term Debt
AU$944.6k
CAGR 3-Years
9%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Pro Medicus Ltd
ASX:PME
Current Portion of Long-Term Debt
AU$553k
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medibio Ltd
ASX:MEB
Current Portion of Long-Term Debt
AU$103.7k
CAGR 3-Years
10%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Medadvisor Ltd
ASX:MDR
Current Portion of Long-Term Debt
AU$12.6m
CAGR 3-Years
100%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Alcidion Group Ltd
ASX:ALC
Current Portion of Long-Term Debt
AU$697k
CAGR 3-Years
62%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

CogState Ltd
Glance View

Market Cap
164.8m AUD
Industry
Health Care

Cogstate Ltd. is a global cognitive science company. The firm provides computerized cognitive tests across various domains and support electronic clinical outcome assessment (eCOA) solutions. The firm's segment includes Clinical trials, Healthcare and Research. In the Clinical trials segment, the Company's technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians to assess cognitive decline. Research segment offers various research studies and academic collaborations across various indication of diseases.

CGS Intrinsic Value
1.607 AUD
Undervaluation 40%
Intrinsic Value
Price

See Also

What is CogState Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
108.4k USD

Based on the financial report for Jun 30, 2024, CogState Ltd's Current Portion of Long-Term Debt amounts to 108.4k USD.

What is CogState Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 3Y
-44%

Over the last year, the Current Portion of Long-Term Debt growth was -54%. The average annual Current Portion of Long-Term Debt growth rates for CogState Ltd have been -44% over the past three years .

Back to Top